Reovirus-based therapy for cancer
- 15 June 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 9 (7) , 817-830
- https://doi.org/10.1517/14712590903002039
Abstract
(2009). Reovirus-based therapy for cancer. Expert Opinion on Biological Therapy: Vol. 9, No. 7, pp. 817-830.Keywords
This publication has 77 references indexed in Scilit:
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor ImmunityClinical Cancer Research, 2008
- Reovirus therapy in cancer: has the orphan virus found a home?Expert Opinion on Investigational Drugs, 2008
- Cancer Cell Death Enhances the Penetration and Efficacy of Oncolytic Herpes Simplex Virus in TumorsCancer Research, 2008
- Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of ReovirusClinical Cancer Research, 2008
- Sensitization to Apoptosis Underlies Kras D12 -Dependent Oncolysis of Murine C26 Colorectal Carcinoma Cells by Reovirus T3DJournal of Virology, 2005
- Prevalence of Reovirus‐Specific Antibodies in Young Children in Nashville, TennesseeThe Journal of Infectious Diseases, 2005
- Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras‐transformed NIH 3T3 cellsMolecular Carcinogenesis, 1992
- The GTPase superfamily: conserved structure and molecular mechanismNature, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The preferential cytotoxicity of reovirus for certain transformed cell linesArchiv für die gesamte Virusforschung, 1977